The 11 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 47.60, with a high estimate of 56.00 and a low estimate of 31.00. The median estimate represents a +12.98% increase from the last price of 42.13.
The current consensus among 11 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.35
Reporting Date Aug 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.